Read time: 3 minutes. Surgery is a treatment option for early-stage lung cancer that involves removing all or part of a lung to treat a cancerous tumor. It is primarily an option
Read time: 3 minutes. Roughly 20% of lung cancer is diagnosed as early-stage disease, and researchers have been working to improve treatment options for these patients—with
Read time: 2 minutes. Researchers have been trying to find new ways to treat small cell lung cancer (SCLC) for a long time. Those efforts are starting to pay off in big ways. Join
Read time: 2 minutes. Here we present the final video in our three-part series about how patients and researchers can work together to develop clinical trials. In the video below
Read time: 2 minutes. We are pleased to continue our three-part series about how patients and researchers can work together to develop clinical trials. In this second video
Read time: 3 minutes. Throughout 2024 we published blogs sharing scientific meeting recaps, educational content, personal stories, treatment news, and so much more. Below are the
How can you help the people you can’t see? For most people the answer is: You can’t. Matty Triplette’s approach is different: Get a flashlight if you have to. Find a way to see
Read time: 2 minutes. Brain metastases (also called brain mets) develop when cancer from somewhere else in the body spreads to the brain. Over time, tumors can become metastatic
Read time: 4 minutes. Anyone with lungs can get lung cancer, and everyone with lungs can raise awareness this November for Lung Cancer Awareness Month. LUNGevity has teamed up with
Read time: 5 minutes. This is Part 3 in our series on how drugs get approved to treat lung cancer. Part 1: Understanding Clinical Trials - Why Are They Important for Drug
On August 15, 2024, the US Food and Drug Administration (FDA) approved a new treatment regimen for people newly diagnosed with early-stage, resectable (able to be removed by
On August 19, 2024, the US Food and Drug Administration (FDA) approved a new treatment option for people newly diagnosed with locally advanced or metastatic non-small cell lung